Selected research
Industry Research
Buprenorphine Hydrochloride Tablets Industry Research Report 2026
Market perspective
The global Buprenorphine Hydrochloride Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Buprenorphine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Buprenorphine Hydrochloride Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Buprenorphine Hydrochloride Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Buprenorphine Hydrochloride Tablets include Arevipharma, Faranshimi, Mallinckrodt, Micro Orgo Chem, Noramco, Resonance-labs, Rusan Pharma, Siegfried and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Buprenorphine Hydrochloride Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (W Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Buprenorphine Hydrochloride Tablets Market by Company
Arevipharma
Faranshimi
Mallinckrodt
Micro Orgo Chem
Noramco
Resonance-labs
Rusan Pharma
Siegfried
Sun Pharma
Unichemlabs
Sanofi
Teva
Johnson Matthey
Buprenorphine Hydrochloride Tablets Segment by Type
0.5mg
2mg
Buprenorphine Hydrochloride Tablets Segment by Application
Analgesic
Opioid Antagonist
Buprenorphine Hydrochloride Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Hydrochloride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Buprenorphine Hydrochloride Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Buprenorphine Hydrochloride Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Buprenorphine Hydrochloride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.5mg
- 2mg
Applications
- Analgesic
- Opioid Antagonist
Companies covered
- Arevipharma
- Faranshimi
- Mallinckrodt
- Micro Orgo Chem
- Noramco
- Resonance-labs
- Rusan Pharma
- Siegfried
- Sun Pharma
- Unichemlabs
- Sanofi
- Teva
- Johnson Matthey
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Buprenorphine Hydrochloride Tablets Market Size (2021-2032)
- 2.2.2 Global Buprenorphine Hydrochloride Tablets Sales (2021-2032)
- 2.2.3 Global Buprenorphine Hydrochloride Tablets Market Average Price (2021-2032)
- 2.3 Buprenorphine Hydrochloride Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.5mg
- 2.3.3 2mg
- 2.4 Buprenorphine Hydrochloride Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Analgesic
- 2.4.3 Opioid Antagonist
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Buprenorphine Hydrochloride Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Buprenorphine Hydrochloride Tablets Sales (W Pcs) of Manufacturers (2021-2026)
- 3.3 Global Buprenorphine Hydrochloride Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Buprenorphine Hydrochloride Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Buprenorphine Hydrochloride Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Buprenorphine Hydrochloride Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Buprenorphine Hydrochloride Tablets, Product Type & Application
- 3.8 Global Manufacturers of Buprenorphine Hydrochloride Tablets, Established Date
- 3.9 Global Buprenorphine Hydrochloride Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Arevipharma
- 4.1.1 Arevipharma Company Information
- 4.1.2 Arevipharma Business Overview
- 4.1.3 Arevipharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Arevipharma Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.1.5 Arevipharma Recent Developments
- 4.2 Faranshimi
- 4.2.1 Faranshimi Company Information
- 4.2.2 Faranshimi Business Overview
- 4.2.3 Faranshimi Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Faranshimi Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.2.5 Faranshimi Recent Developments
- 4.3 Mallinckrodt
- 4.3.1 Mallinckrodt Company Information
- 4.3.2 Mallinckrodt Business Overview
- 4.3.3 Mallinckrodt Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mallinckrodt Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.3.5 Mallinckrodt Recent Developments
- 4.4 Micro Orgo Chem
- 4.4.1 Micro Orgo Chem Company Information
- 4.4.2 Micro Orgo Chem Business Overview
- 4.4.3 Micro Orgo Chem Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Micro Orgo Chem Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.4.5 Micro Orgo Chem Recent Developments
- 4.5 Noramco
- 4.5.1 Noramco Company Information
- 4.5.2 Noramco Business Overview
- 4.5.3 Noramco Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Noramco Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.5.5 Noramco Recent Developments
- 4.6 Resonance-labs
- 4.6.1 Resonance-labs Company Information
- 4.6.2 Resonance-labs Business Overview
- 4.6.3 Resonance-labs Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Resonance-labs Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.6.5 Resonance-labs Recent Developments
- 4.7 Rusan Pharma
- 4.7.1 Rusan Pharma Company Information
- 4.7.2 Rusan Pharma Business Overview
- 4.7.3 Rusan Pharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Rusan Pharma Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.7.5 Rusan Pharma Recent Developments
- 4.8 Siegfried
- 4.8.1 Siegfried Company Information
- 4.8.2 Siegfried Business Overview
- 4.8.3 Siegfried Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Siegfried Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.8.5 Siegfried Recent Developments
- 4.9 Sun Pharma
- 4.9.1 Sun Pharma Company Information
- 4.9.2 Sun Pharma Business Overview
- 4.9.3 Sun Pharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sun Pharma Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.9.5 Sun Pharma Recent Developments
- 4.10 Unichemlabs
- 4.10.1 Unichemlabs Company Information
- 4.10.2 Unichemlabs Business Overview
- 4.10.3 Unichemlabs Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Unichemlabs Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.10.5 Unichemlabs Recent Developments
- 4.11 Sanofi
- 4.11.1 Sanofi Company Information
- 4.11.2 Sanofi Business Overview
- 4.11.3 Sanofi Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sanofi Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.11.5 Sanofi Recent Developments
- 4.12 Teva
- 4.12.1 Teva Company Information
- 4.12.2 Teva Business Overview
- 4.12.3 Teva Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Teva Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.12.5 Teva Recent Developments
- 4.13 Johnson Matthey
- 4.13.1 Johnson Matthey Company Information
- 4.13.2 Johnson Matthey Business Overview
- 4.13.3 Johnson Matthey Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Johnson Matthey Buprenorphine Hydrochloride Tablets Product Portfolio
- 4.13.5 Johnson Matthey Recent Developments
5 Global Buprenorphine Hydrochloride Tablets Market Scenario by Region
- 5.1 Global Buprenorphine Hydrochloride Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Buprenorphine Hydrochloride Tablets Sales by Region: 2021-2032
- 5.2.1 Global Buprenorphine Hydrochloride Tablets Sales by Region: 2021-2026
- 5.2.2 Global Buprenorphine Hydrochloride Tablets Sales by Region: 2027-2032
- 5.3 Global Buprenorphine Hydrochloride Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Buprenorphine Hydrochloride Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Buprenorphine Hydrochloride Tablets Revenue by Region: 2027-2032
- 5.4 North America Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
- 5.4.1 North America Buprenorphine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Buprenorphine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.4.3 North America Buprenorphine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
- 5.5.1 Europe Buprenorphine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Buprenorphine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Buprenorphine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Buprenorphine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Buprenorphine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Buprenorphine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
- 5.7.1 South America Buprenorphine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Buprenorphine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.7.3 South America Buprenorphine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Buprenorphine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Buprenorphine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Buprenorphine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Buprenorphine Hydrochloride Tablets Sales by Type (2021-2032)
- 6.1.1 Global Buprenorphine Hydrochloride Tablets Sales by Type (2021-2032) & (W Pcs)
- 6.1.2 Global Buprenorphine Hydrochloride Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Buprenorphine Hydrochloride Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Buprenorphine Hydrochloride Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Buprenorphine Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Buprenorphine Hydrochloride Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Buprenorphine Hydrochloride Tablets Sales by Application (2021-2032)
- 7.1.1 Global Buprenorphine Hydrochloride Tablets Sales by Application (2021-2032) & (W Pcs)
- 7.1.2 Global Buprenorphine Hydrochloride Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Buprenorphine Hydrochloride Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Buprenorphine Hydrochloride Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Buprenorphine Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Buprenorphine Hydrochloride Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Buprenorphine Hydrochloride Tablets Value Chain Analysis
- 8.1.1 Buprenorphine Hydrochloride Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Buprenorphine Hydrochloride Tablets Production Mode & Process
- 8.2 Buprenorphine Hydrochloride Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Buprenorphine Hydrochloride Tablets Distributors
- 8.2.3 Buprenorphine Hydrochloride Tablets Customers
9 Global Buprenorphine Hydrochloride Tablets Analyzing Market Dynamics
- 9.1 Buprenorphine Hydrochloride Tablets Industry Trends
- 9.2 Buprenorphine Hydrochloride Tablets Industry Drivers
- 9.3 Buprenorphine Hydrochloride Tablets Industry Opportunities and Challenges
- 9.4 Buprenorphine Hydrochloride Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst